Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature

被引:13
|
作者
Reynaert, Hendrik [1 ,2 ]
Colle, Isabelle [3 ,4 ]
机构
[1] UZBrussel, Dept Gastroenterol Hepatol, Laarbeeklaan 101, B-1090 Brussels, Belgium
[2] Vrije Univ Brussel, Liver Cell Biol Lab, Laarbeeklaan 103, B-1090 Brussels, Belgium
[3] ASZ Aalst, Dept Gastroenterol Hepatol, Merestr 80, B-9300 Aalst, Belgium
[4] Univ Ghent, Dept Gastroenterol Hepatol, Pintelaan, B-9000 Ghent, Belgium
关键词
hepatocellular carcinoma; octreotide; somatostatin; somatostatin analogues; somatostatin receptor; LONG-ACTING OCTREOTIDE; RECEPTOR SUBTYPES; PLUS OCTREOTIDE; PLACEBO; MULTICENTER; EXPRESSION; TUMOR; PROLIFERATION; PASIREOTIDE; SORAFENIB;
D O I
10.3390/ijms20194811
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma, one of the most dreaded complications of cirrhosis, is a frequent cancer with high mortality. Early primary liver cancer can be treated by surgery or ablation techniques, but advanced hepatocellular carcinoma remains a challenge for clinicians. Most of these patients have underlying cirrhosis, which complicates or even precludes treatment. Therefore, efficacious treatments without major side effects are welcomed. Initial results of treatment of advanced hepatocellular carcinoma with somatostatin analogues were promising, but subsequent trials have resulted in conflicting outcomes. This might be explained by different patient populations, differences in dosage and type of treatment and differences in somatostatin receptor expression in the tumor or surrounding tissue. It has been shown that the expression of somatostatin receptors in the tumor might be of importance to select patients who could benefit from treatment with somatostatin analogues. Moreover, somatostatin receptor expression in hepatocellular carcinoma has been shown to correlate with recurrence, prognosis, and survival. In this review, we will summarize the available data on treatment of primary liver cancer with somatostatin analogues and analyze the current knowledge of somatostatin receptor expression in hepatocellular carcinoma and its possible clinical impact.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The Treatment Landscape of Advanced Hepatocellular Carcinoma
    Wong, Kit Man
    King, Gentry G.
    Harris, William P.
    CURRENT ONCOLOGY REPORTS, 2022, 24 (07) : 917 - 927
  • [42] The Treatment Landscape of Advanced Hepatocellular Carcinoma
    Kit Man Wong
    Gentry G. King
    William P. Harris
    Current Oncology Reports, 2022, 24 : 917 - 927
  • [43] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [44] Multidisciplinary Treatment of Advanced Hepatocellular Carcinoma
    Yang, Zhe
    Abdrakhimov, Bulat
    Wang, Shuo
    Xie, Qin-Fen
    Zheng, Shu-Sen
    CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (01) : 98 - 102
  • [45] Treatment of large and advanced hepatocellular carcinoma
    Abdalla, Eddie K.
    Denys, Alban
    Hasegawa, Kiyoshi
    Leung, Thomas W. T.
    Makuuchi, Masatoshi
    Murthy, Ravi
    Ribero, Dario
    Zorzi, Daria
    Vauthey, Jean-Nicolas
    Torzilli, Guido
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) : 979 - 985
  • [46] Capecitabine for treatment of advanced hepatocellular carcinoma
    von Delius, S.
    Lersch, C.
    Mayr, M.
    Stock, K.
    Schulte-Frohlinde, E.
    Schmid, R. M.
    Eckel, F.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2310 - 2314
  • [47] Somatostatin analogues have no role in the treatment of advanced differentiated thyroid cancer
    Alhamarneh, O
    Murphy, J
    Atkin, SL
    England, RJA
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2004, 118 (08): : 653 - 654
  • [48] Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues
    Van Eijck, CHJ
    BRITISH JOURNAL OF SURGERY, 2005, 92 (11) : 1333 - 1334
  • [49] The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma
    Vainas, G
    Pasaitou, V
    Galaktidou, G
    Maris, K
    Christodoulou, K
    Constantinidis, C
    Kortsaris, AH
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1997, 16 (01): : 119 - 126
  • [50] Surgical treatment of synchronous hepatocellular and esophageal carcinoma: Case report and review of literature
    Pelloni, A
    Guerra, A
    Gertsch, P
    HEPATO-GASTROENTEROLOGY, 2001, 48 (39) : 684 - 686